These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29210342)

  • 21. Evidence that a novel quaternary compound and its organic N-chloramine derivative do not select for resistant mutants of Pseudomonas aeruginosa.
    De Silva M; Ning C; Ghanbar S; Zhanel G; Logsetty S; Liu S; Kumar A
    J Hosp Infect; 2015 Sep; 91(1):53-8. PubMed ID: 26122622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel indole compound that inhibits Pseudomonas aeruginosa growth by targeting MreB is a substrate for MexAB-OprM.
    Robertson GT; Doyle TB; Du Q; Duncan L; Mdluli KE; Lynch AS
    J Bacteriol; 2007 Oct; 189(19):6870-81. PubMed ID: 17644596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG).
    Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH
    Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs.
    Lister PD; Wolter DJ; Wickman PA; Reisbig MD
    J Antimicrob Chemother; 2006 May; 57(5):999-1003. PubMed ID: 16513915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran.
    Goli HR; Nahaei MR; Rezaee MA; Hasani A; Samadi Kafil H; Aghazadeh M; Sheikhalizadeh V
    Infect Genet Evol; 2016 Nov; 45():75-82. PubMed ID: 27562333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of mex-gene products in antibiotic extrusion in Pseudomonas aeruginosa.
    Yoneyama H; Ocaktan A; Tsuda M; Nakae T
    Biochem Biophys Res Commun; 1997 Apr; 233(3):611-8. PubMed ID: 9168899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutational analyses of regulatory genes, mexR, nalC, nalD and mexZ of mexAB-oprM and mexXY operons, in efflux pump hyperexpressing multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    Suresh M; Nithya N; Jayasree PR; Vimal KP; Manish Kumar PR
    World J Microbiol Biotechnol; 2018 May; 34(6):83. PubMed ID: 29846800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assembly of the MexAB-OprM multidrug pump of Pseudomonas aeruginosa: component interactions defined by the study of pump mutant suppressors.
    Nehme D; Poole K
    J Bacteriol; 2007 Sep; 189(17):6118-27. PubMed ID: 17586626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inner membrane efflux components are responsible for beta-lactam specificity of multidrug efflux pumps in Pseudomonas aeruginosa.
    Srikumar R; Li XZ; Poole K
    J Bacteriol; 1997 Dec; 179(24):7875-81. PubMed ID: 9401051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of MexAB-OprM and MexXY-OprM efflux pumps and class 1 integrons in resistance to antibiotics in burn and Intensive Care Unit isolates of Pseudomonas aeruginosa.
    Goli HR; Nahaei MR; Rezaee MA; Hasani A; Kafil HS; Aghazadeh M; Nikbakht M; Khalili Y
    J Infect Public Health; 2018; 11(3):364-372. PubMed ID: 28993173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticle Fullerene (C60) demonstrated stable binding with antibacterial potential towards probable targets of drug resistant Salmonella typhi - a computational perspective and in vitro investigation.
    Skariyachan S; Parveen A; Garka S
    J Biomol Struct Dyn; 2017 Dec; 35(16):3449-3468. PubMed ID: 27817242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RELATIVE EXPRESSION OF EFFLUX PUMPS IN MULTI DRUG RESISTANT PSEUDOMONAS AERUGINOSA.
    Azimi L; Namvar AE; Jamali S; Lari AR; Bijari A; Lari AR
    Roum Arch Microbiol Immunol; 2015; 74(3-4):86-90. PubMed ID: 27328522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant, Non-Carbapenemase-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms.
    Wi YM; Greenwood-Quaintance KE; Schuetz AN; Ko KS; Peck KR; Song JH; Patel R
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29133568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative contribution of efflux to multi-drug resistance of clinical Escherichia coli and Pseudomonas aeruginosa strains.
    Cunrath O; Meinel DM; Maturana P; Fanous J; Buyck JM; Saint Auguste P; Seth-Smith HMB; Körner J; Dehio C; Trebosc V; Kemmer C; Neher R; Egli A; Bumann D
    EBioMedicine; 2019 Mar; 41():479-487. PubMed ID: 30852163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of the MexA and MexB components of the MexAB-OprM multidrug efflux system of Pseudomonas aeruginosa: identification of MexA extragenic suppressors of a T578I mutation in MexB.
    Nehme D; Poole K
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4375-8. PubMed ID: 16189126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meropenem potentiation of aminoglycoside activity against Pseudomonas aeruginosa: involvement of the MexXY-OprM multidrug efflux system.
    Poole K; Gilmour C; Farha MA; Parkins MD; Klinoski R; Brown ED
    J Antimicrob Chemother; 2018 May; 73(5):1247-1255. PubMed ID: 29420743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ.
    Chuanchuen R; Beinlich K; Hoang TT; Becher A; Karkhoff-Schweizer RR; Schweizer HP
    Antimicrob Agents Chemother; 2001 Feb; 45(2):428-32. PubMed ID: 11158736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of efflux pump inhibitor in decreasing antibiotic cross-resistance of Pseudomonas aeruginosa in a burn hospital in Iran.
    Talebi-Taher M; Majidpour َ; Gholami A; Rasouli-Kouhi S; Adabi M
    J Infect Dev Ctries; 2016 Jun; 10(6):600-4. PubMed ID: 27367008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro bactericidal activity of promising nutraceuticals for targeting multidrug resistant Pseudomonas aeruginosa.
    Chakotiya AS; Chawla R; Thakur P; Tanwar A; Narula A; Grover SS; Goel R; Arora R; Sharma RK
    Nutrition; 2016; 32(7-8):890-7. PubMed ID: 27083519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect and mechanism of andrographolide on the recovery of Pseudomonas aeruginosa susceptibility to several antibiotics.
    Wu CM; Cao JL; Zheng MH; Ou Y; Zhang L; Zhu XQ; Song JX
    J Int Med Res; 2008; 36(1):178-86. PubMed ID: 18304418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.